A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Of Oral Rpc1063 As Induction And Maintenance Therapy For Moderate To Severe
Posted Date: May 15, 2019
- Investigator: Gorman Reynolds
- Type of Study: Drug
Receptos
Criteria:
You Have Been Asked To Join This Study Because You Are Being Treated For Moderate Or Severe Uc And Y
Keywords:
Inflammatory Bowel D, Ulcerative Colitis
For More Information:
Renee Henry
513-558-5504
henryr4@ucmail.uc.edu